| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 13.214 | 16.750 | 16.796 | 26.142 | 28.093 | 39.854 | 71.487 |
| Total Income - EUR | - | - | - | 13.214 | 16.750 | 16.796 | 26.142 | 28.410 | 41.977 | 72.092 |
| Total Expenses - EUR | - | - | - | 5.171 | 13.450 | 14.742 | 17.765 | 21.320 | 27.828 | 39.851 |
| Gross Profit/Loss - EUR | - | - | - | 8.043 | 3.300 | 2.054 | 8.376 | 7.090 | 14.149 | 32.241 |
| Net Profit/Loss - EUR | - | - | - | 7.647 | 2.798 | 1.584 | 7.670 | 6.340 | 11.534 | 30.402 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Yct Rx Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 14.022 | 10.083 | 6.295 | 2.638 | 4.451 | 30.455 | 25.094 |
| Current Assets | - | - | - | 78 | 935 | 5.700 | 16.902 | 15.627 | 1.285 | 37.517 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 3 | 0 | 370 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 1.903 | 0 | 5.760 |
| Cash | - | - | - | 78 | 935 | 5.700 | 16.902 | 13.720 | 1.285 | 1.233 |
| Shareholders Funds | - | - | - | 7.689 | 10.338 | 11.727 | 19.137 | 19.331 | 30.807 | 61.037 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 6.410 | 681 | 269 | 403 | 746 | 933 | 1.574 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Yct Rx Med S.r.l.